The case for entrepreneurship in R&D in the pharmaceutical industry

被引：0

作者：

Frank L. Douglas

V. K. Narayanan

Lesa Mitchell

Robert E. Litan

机构：

[1] Frank L. Douglas,

[2] Lesa Mitchell and Robert E. Litan are at the Ewing Marion Kauffman Foundation,undefined

[3] Kansas City,undefined

[4] Missouri,undefined

[5] USA.,undefined

[6] Frank L. Douglas is also at the Austen BioInnovation Institute,undefined

[7] Akron,undefined

[8] Ohio,undefined

[9] USA.,undefined

[10] V. K. Narayanan is at the Center for Research Excellence,undefined

[11] LeBow College of Business,undefined

[12] Drexel University,undefined

[13] Philadelphia,undefined

[14] Pennsylvania,undefined

[15] USA.,undefined

来源：

Nature Reviews Drug Discovery | 2010年 / 9卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

A lack of entrepreneurial behaviour has often been identified as a contributor to the decline in the research and development (R&D) productivity of the pharmaceutical industry. Douglas and colleagues present an assessment of entrepreneurship in the industry, based on interviews with 26 former and current leaders of R&D departments at pharmaceutical and biotechnology companies, highlighting factors that could be important in promoting entrepreneurial behaviour and revitalizing R&D productivity.

引用

页码：683 / 689

页数：6

共 50 条

[1] The case for entrepreneurship in R&D in the pharmaceutical industry
Douglas, Frank L.
Narayanan, V. K.
Mitchell, Lesa
Litan, Robert E.
[J]. NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (09) : 683 - 689
[2] R&D EFFECTIVENESS IN THE PHARMACEUTICAL INDUSTRY
Konopielko, Lukasz
Trehubova, Anastasiia
[J]. ECONOMIC AND SOCIAL DEVELOPMENT (ESD 2018): 33RD INTERNATIONAL SCIENTIFIC CONFERENCE ON ECONOMIC AND SOCIAL DEVELOPMENT "MANAGERIAL ISSUES IN MODERN BUSINESS", 2018, : 287 - 296
[3] Leading R&D in the pharmaceutical industry
Scolnick, EM
[J]. RESEARCH-TECHNOLOGY MANAGEMENT, 2000, 43 (03) : 35 - 38
[4] Marketing/R&D integration in the pharmaceutical industry
Becker, MC
Lillemark, M
[J]. RESEARCH POLICY, 2006, 35 (01) : 105 - 120
[5] An assessment of R&D productivity in the pharmaceutical industry
Dimitri, Nicola
[J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2011, 32 (12) : 683 - 685
[6] Pharmaceutical industry R&D alliance: compulsions and challenges
Pandey, M
Chaturvedi, M
[J]. CHIMICA OGGI-CHEMISTRY TODAY, 2005, 23 (01) : 28 - 30
[7] R&D in the pharmaceutical industry and the US investment in innovation
Wollowitz, S
Kermani, F
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U251 - U251
[8] The outsourcing of R&D through acquisitions in the pharmaceutical industry
Higgins, Matthew J.
Rodriguez, Daniel
[J]. JOURNAL OF FINANCIAL ECONOMICS, 2006, 80 (02) : 351 - 383
[9] Measuring US Pharmaceutical Industry R&D Spending
Golec, Joseph
Vernon, John
[J]. PHARMACOECONOMICS, 2008, 26 (12) : 1005 - 1017
[10] Virtual R&D organisations: Lessons for the pharmaceutical industry
Chiesa, V
Manzini, R
[J]. INNOVATION IN TECHNOLOGY MANAGEMENT - THE KEY TO GLOBAL LEADERSHIP: THE KEY TO GLOBAL LEADERSHIP, 1997, : 520 - 523

← 1 2 3 4 5 →